加载中
AMEXHealthcareMedical - Care Facilities
最新数据
US$4.36
+US$0.19 · +4.56%
Cryo-Cell International, Inc. engages in cord blood and cord tissue cryopreservation services in the United States. The company offers cellular processing and cryogenic storage for family use, primarily for collection and preservation of umbilical cord blood, and tissue stem cells; and cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. It is also involved in the manufacturing of PrepaCyte CB processing system units for processing umbilical cord blood stem cells. In addition, the company provides cold storage services to third-party pharmaceutical companies and medical institutions. It markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals. The company was incorporated in 1989 and is headquartered in Oldsmar, Florida.
前收盘价
US$4.36
+US$0.19 · +4.56%
盘中时间采用ET。市场数据可能有所延迟。
Cryo-Cell International, Inc. engages in cord blood and cord tissue cryopreservation services in the United States. The company offers cellular processing and cryogenic storage for family use, primarily for collection and preservation of umbilical cord blood, and tissue stem cells; and cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. It is also involved in the manufacturing of PrepaCyte CB processing system units for processing umbilical cord blood stem cells. In addition, the company provides cold storage services to third-party pharmaceutical companies and medical institutions. It markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals. The company was incorporated in 1989 and is headquartered in Oldsmar, Florida.
日内区间
当前US$4.36
52周区间
当前US$4.36
盘中时间采用ET。市场数据可能有所延迟。
Cryo-Cell International, Inc. engages in cord blood and cord tissue cryopreservation services in the United States. The company offers cellular processing and cryogenic storage for family use, primarily for collection and preservation of umbilical cord blood, and tissue stem cells; and cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. It is also involved in the manufacturing of PrepaCyte CB processing system units for processing umbilical cord blood stem cells. In addition, the company provides cold storage services to third-party pharmaceutical companies and medical institutions. It markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals. The company was incorporated in 1989 and is headquartered in Oldsmar, Florida.
日内区间
当前US$4.36
52周区间
当前US$4.36
盈利能力占已公布营收的百分比。
营收
营业利润
净利润
| 项目（USD） | 2025财年 | 2024财年 | 2023财年 | 2022财年 | 2021财年 |
|---|---|---|---|---|---|
| 营收 | 3156.63万 USD | 3198.61万 USD | 3134.37万 USD | 3033.67万 USD | 2888.49万 USD |
| 销货成本 | 737.66万 USD | 794.78万 USD | 844.23万 USD | 879.24万 USD | 898.97万 USD |
| 毛利 | 2418.97万 USD | 2403.84万 USD | 2290.14万 USD | 2154.44万 USD | 1989.52万 USD |
| 研究与开发 | 37.63万 USD | 124.25万 USD | 117.15万 USD | 38.48万 USD | 4.99万 USD |
| 销售、一般及管理费用 | 1822.07万 USD | 1852.12万 USD | 1711.55万 USD | 1558.03万 USD | 1462.53万 USD |
| 营业费用 | 1934.84万 USD | 2055.81万 USD | 3520.54万 USD | 1751.99万 USD | 1587.69万 USD |
| 利息支出 | 206.63万 USD | 186.47万 USD | 123.68万 USD | 152.18万 USD | 137.89万 USD |
| 折旧和摊销 | 136.81万 USD | 102.16万 USD | 171.04万 USD | 180.93万 USD | 132.64万 USD |
| 营业利润 | 484.12万 USD | 348.03万 USD | −1230.4万 USD | 402.45万 USD | 401.82万 USD |
| 净利润 | −242.94万 USD | 40.21万 USD | −952.17万 USD | 277.14万 USD | 208.35万 USD |
公司数据更新于 2026年10月11日。
近期已公布业绩
近期已公布业绩
报告持有此股票敞口的交易所交易基金。
AI 生成内容及延迟市场数据仅供信息与教育用途，不构成投资建议。
